XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Stock award plan - (Tables)
9 Months Ended
Sep. 30, 2024
Share-based Payment Arrangement [Abstract]  
Summary of stock option activity

    

    

    

Weighted-

    

  

Weighted-

average

Aggregate

average

remaining

intrinsic

Number of

exercise

contractual

value(in 

options

price

term

thousands)

 

Outstanding at December 31, 2023

 

9,600,399

$

43.59

 

  

 

  

Granted

 

934,735

26.13

 

  

 

  

Exercised

 

(211,693)

22.41

 

  

 

  

Forfeited/Cancelled

 

(1,149,981)

45.86

 

  

 

  

Outstanding at September 30, 2024

 

9,173,460

$

42.01

 

5.64

years

$

30,906

Vested or Expected to vest at September 30, 2024

 

1,746,884

$

35.85

 

8.45

years

$

9,289

Exercisable at September 30, 2024

 

7,254,847

$

43.74

 

4.89

years

$

20,420

Schedule of assumptions used to estimate fair values of grants made on the date of grant

    

Nine months ended

    

    

September 30, 2024

    

Risk-free interest rate

 

3.51% - 4.66%

 

Expected volatility

 

53% - 54%

 

Expected term

 

5.5 years

 

Summary of information on the Company's restricted stock

Restricted Stock Units

Weighted

Average

Grant

Number of

Date

    

Shares

    

Fair Value

Unvested at December 31, 2023

2,866,270

$

41.82

Granted

 

1,850,265

25.87

Vested

 

(924,417)

44.08

Forfeited

 

(195,789)

37.28

Unvested at September 30, 2024

 

3,596,329

$

33.29

Schedule of share-based compensation expense recorded in the statement of operations

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2024

    

2023

    

2024

    

2023

Research and development

$

9,416

$

13,986

$

27,810

$

44,828

Selling, general and administrative

 

10,339

 

12,956

 

29,566

 

40,300

Total

$

19,755

$

26,942

$

57,376

$

85,128